2Bugianesi E, Manzini P, D'Antico S, et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver[J]. Hepatology, 2004, 39:179-187.
3Patel T, Gores G J. Apoptosis and hepatobiliary disease[J]. Hepatology, 1995, 21: 1725-1741.
4Marchesini G, Marzocchi R. Metabolic syndrome and NASH [J]. ClinLiverDis, 2007, 11: 105-117.
5Ong J P, Younossi Z M. Epidemiology and natural history of NAFLD and NASH [J]. Clin Liver Dis,2007, 11: 1-16.
6Wieckowska A, Zein N N, Yerian L M, etal. In vivo assess ment of liver cell apoptosis as a novel biomarker of disease se- verity in nonalcoholic fatty liver disease [J]. Hepatology, 2006, 44: 27-33.
7Nishitani Y, Okazaki S, Imabayashi K, et al. Saturated and monounsaturated fatty acids increase interleukin-10 production in rat hepatocytes [J]. Nihon Arukoru Yakubutsu Igakkai Zasshi, 2007, 42: 32-35.
